Sugemalimab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Sugemalimab, covering 2023-08-07 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma [Phase 3]